Report on transactions of executives and related parties in Coloplast shares and related securities
According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.
The below transactions concern allocation of share options.
For further details, reference is made to Coloplast’s Remuneration Policy. The policy is available on the group website at this address:
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Kristian Villumsen
2
Reason for the notification
a)
Position/status
President & CEO
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
a)
Name
Coloplast A/S (CVR-no.: 69749917)
b)
LEI
529900NN7SOJ5QG82X67
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Share options relating to B shares
Identification code
ISIN: DK0060448595 (B shares)
b)
Nature of the transaction
Share option allocation
c)
Price and volume
Price
Volume
0.00
49,153
d)
Aggregated information
- Aggregated volume
49,153 share options
- Price
DKK 0.00
e)
Date of the transaction
2024-02-09, 13:30 UTC
f)
Place of the transaction
Outside a trading venue
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Anders Lonning-Skovgaard
2
Reason for the notification
a)
Position/status
Executive Vice President & CFO
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
a)
Name
Coloplast A/S (CVR-no.: 69749917)
b)
LEI
529900NN7SOJ5QG82X67
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Share options relating to B shares
Identification code
ISIN: DK0060448595 (B shares)
b)
Nature of the transaction
Share option allocation
c)
Price and volume
Price
Volume
0.00
25,021
d)
Aggregated information
- Aggregated volume
25,021 share options
- Price
DKK 0.00
e)
Date of the transaction
2024-02-09, 13:30 UTC
f)
Place of the transaction
Outside a trading venue
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Paul Marcun
2
Reason for the notification
a)
Position/status
Executive Vice President, Growth
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
a)
Name
Coloplast A/S (CVR-no.: 69749917)
b)
LEI
529900NN7SOJ5QG82X67
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Share options relating to B shares
Identification code
ISIN: DK0060448595 (B shares)
b)
Nature of the transaction
Share option allocation
c)
Price and volume
Price
Volume
0.00
24,909
d)
Aggregated information
- Aggregated volume
24,909 share options
- Price
DKK 0.00
e)
Date of the transaction
2024-02-09, 13:30 UTC
f)
Place of the transaction
Outside a trading venue
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Allan Rasmussen
2
Reason for the notification
a)
Position/status
Executive Vice President, Global Operations
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
a)
Name
Coloplast A/S (CVR-no.: 69749917)
b)
LEI
529900NN7SOJ5QG82X67
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Share options relating to B shares
Identification code
ISIN: DK0060448595 (B shares)
b)
Nature of the transaction
Share option allocation
c)
Price and volume
Price
Volume
0.00
21,828
d)
Aggregated information
- Aggregated volume
21,828 share options
- Price
DKK 0.00
e)
Date of the transaction
2024-02-09, 13:30 UTC
f)
Place of the transaction
Outside a trading venue
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Nicolai Buhl Andersen
2
Reason for the notification
a)
Position/status
Executive Vice President, Innovation
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
a)
Name
Coloplast A/S (CVR-no.: 69749917)
b)
LEI
529900NN7SOJ5QG82X67
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Share options relating to B shares
Identification code
ISIN: DK0060448595 (B shares)
b)
Nature of the transaction
Share option allocation
c)
Price and volume
Price
Volume
0.00
20,615
d)
Aggregated information
- Aggregated volume
20,615 share options
- Price
DKK 0.00
e)
Date of the transaction
2024-02-09, 13:30 UTC
f)
Place of the transaction
Outside a trading venue
For further information, please contact
Investors and analysts Anders Lonning-Skovgaard Executive Vice President, CFO Tel. +45 4911 1111
This announcement is available in a Danish and an English-language version. In the event of discrepancies, the English version shall prevail.
Coloplast was founded on passion, ambition, and commitment. We were born from a nurse’s wish to help her sister and the skills of an engineer. Guided by empathy, our mission is to make life easier for people with intimate healthcare needs. Over decades, we have helped millions of people to live a more independent life and we continue to do so through innovative products and services. Globally, our business areas include Ostomy Care, Continence Care, Advanced Wound Care, Interventional Urology and Voice and Respiratory Care.
The Coloplast logo is a registered trademark of Coloplast A/S. ? 2024-02.
All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.
